Should patients with nonproliferative diabetic retinopathy be treated early with prophylactic anti-VEGF therapy?
At the virtual Euretina congress, Jennifer Sun, MD, MPH, speaks about the results of Protocol W and the PANORAMA trial and the questions that still remain.